Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Significance of the autoantibody assay in predicting the development of immune-related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Muraoka M, Suzuki Y, Sato M, Kobayashi S, Yoshida T, Takano S, Maekawa S, Enomoto N. Takada H, et al. Among authors: komiyama y. Hepatol Res. 2024 Feb;54(2):162-173. doi: 10.1111/hepr.13969. Epub 2023 Oct 6. Hepatol Res. 2024. PMID: 37740643
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.
Matsuda S, Maekawa S, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Miura M, Amemiya F, Shindo H, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Sato T, Yamashita A, Moriishi K, Enomoto N. Matsuda S, et al. Among authors: komiyama y. Hepatol Res. 2021 Jan;51(1):39-50. doi: 10.1111/hepr.13574. Epub 2021 Jan 11. Hepatol Res. 2021. PMID: 32961003
Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus.
Yasui Y, Kurosaki M, Komiyama Y, Takada H, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Kubota Y, Higuchi M, Takaura K, Tsuchiya K, Nakanishi H, Takahashi Y, Itakura J, Enomoto N, Izumi N. Yasui Y, et al. Among authors: komiyama y. Hepatol Res. 2018 Dec;48(13):1131-1139. doi: 10.1111/hepr.13233. Epub 2018 Aug 23. Hepatol Res. 2018. PMID: 30030872
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.
Katoh R, Maekawa S, Osawa L, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Enomoto N. Katoh R, et al. Among authors: komiyama y. Hepatol Res. 2023 Apr;53(4):280-288. doi: 10.1111/hepr.13861. Epub 2022 Dec 13. Hepatol Res. 2023. PMID: 36445119
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.
Yasui Y, Tsuchiya K, Kurosaki M, Takeguchi T, Takeguchi Y, Okada M, Wang W, Kubota Y, Goto T, Komiyama Y, Higuchi M, Takaura K, Hayashi T, Takada H, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Himeno Y, Izumi N. Yasui Y, et al. Among authors: komiyama y. Hepatol Res. 2018 May;48(6):442-450. doi: 10.1111/hepr.13048. Epub 2018 Feb 9. Hepatol Res. 2018. PMID: 29278654
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
Suzuki Y, Maekawa S, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Takada H, Muraoka M, Sato M, Takano S, Fukasawa M, Yamaguchi T, Funayama S, Morisaka H, Onishi H, Enomoto N. Suzuki Y, et al. Among authors: komiyama y. J Gastroenterol Hepatol. 2023 Jun;38(6):921-929. doi: 10.1111/jgh.16154. Epub 2023 Mar 5. J Gastroenterol Hepatol. 2023. PMID: 36811251
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Takano S, Fukasawa M, Yamaguchi T, Maekawa S, Enomoto N. Takada H, et al. Among authors: komiyama y. Oncology. 2023;101(3):173-184. doi: 10.1159/000527752. Epub 2022 Dec 14. Oncology. 2023. PMID: 36516803
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.
Yasui Y, Abe T, Kurosaki M, Higuchi M, Komiyama Y, Yoshida T, Hayashi T, Kuwabara K, Takaura K, Nakakuki N, Takada H, Tamaki N, Suzuki S, Nakanishi H, Tsuchiya K, Itakura J, Takahashi Y, Hashiguchi A, Sakamoto M, Izumi N. Yasui Y, et al. Among authors: komiyama y. PLoS One. 2016 Apr 29;11(4):e0154558. doi: 10.1371/journal.pone.0154558. eCollection 2016. PLoS One. 2016. PMID: 27128435 Free PMC article.
247 results